At the time of renal scintigraphy, the frequency of acute kidney injury was higher in patients with renal infarction, and the likelihood of renal infarction diagnosis according to the presence or ...

Secondary analysis findings from the EMPACT-MI trial highlight empagliflozin's significant cardiovascular and kidney benefits when initiated soon after an acute myocardial infarction.

Acute kidney injury in a context of cardiac amyloidosis may be due to renal infarction, report scientists in a new study published in Mayo Clinic Proceedings Rochester, MN, May 15, 2019 - Systemic ...

For patients with acute MI at increased risk for HF, empagliflozin showed cardiorenal benefits and was safe to initiate early ...

Renal infarction in cardiac amyloidosis may not be as rare as previously thought, especially in patients with acute kidney injury (AKI), according to a French study recently published in the Mayo ...

Patients With Renal Disease Under-treated After Myocardial Infarction Date: September 7, 2009 Source: Karolinska Institutet Summary: People with kidney disease undergo balloon dilation treatment ...

Acute renal infarction is a rare, yet potentially devastating condition marked by the sudden interruption of blood supply to the renal parenchyma, often resulting in irreversible tissue damage.

Total adverse events of heart failure or all-cause mortality were reduced with empagliflozin, regardless of kidney function.

Empagliflozin has kidney protective effects and reduces heart failure outcomes across baseline kidney function among patients with acute myocardial infarction (MI), according to a study published ...